NOS2 and systemic sclerosis: In addition, we did not find a difference in CANO between control subjects with ILD/COPD and patients with PH due to lung diseases, as also shown for patients with systemic sclerosis with and without PAH [21], which is consistent with the hypothesis that increased CANO may reflect alveolar/acinar inflammation due to iNOS activity.